Film formulations containing dexmedetomidine and methods of producing them
US11559484B2 · kind B2 · utility
8Cited by
81References
29Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 24, 2020 |
| Grant date | Jan 24, 2023 |
| Priority date | — |
| Expiry date | Mar 9, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is a self-supporting, dissolvable, film containing dexmedetomidine or a pharmaceutically acceptable salt thereof. The film is administered orally to treat various conditions, particularly agitation, by transmucosal delivery of the active agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.